The "Fast Money" traders share their first moves ahead of the holiday weekend.
The "Fast Money" traders share their final trades of the day, including Hawaiian Airlines, Starbucks and more.
While the White House and Congress struggled to repeal Obamacare, investors did not shy away from health-care stocks in the first quarter.
Hospital stocks were largely trading in red territory on Tuesday, after an upbeat day Monday.
Hospital-related stocks started the week in the green following the failure of the GOP's effort to replace Obamacare.
This analyst says the hospital stocks' rally might not continue, even with Obamacare remaining intact.
Sheryl Skolnick, Mizuho, discusses why hospitals could suffer with or without the American Health Care Act.
Some of the names on the move ahead of the open.
Hospital stocks continue their three-day rally as the GOP health-care bill got postponed for the second time on Friday.
Health-care stock performance diverged Friday after the controversial GOP health care bill was pulled from the floor of the House.
CNBC's Bertha Coombs breaks down the health-care stocks making moves as House Republicans gear up for a vote on the American Health Care Act.
The strong backlash from conservative Republicans and medical groups has some investors betting cuts will be rolled back.
Health-care stocks saw the biggest losses Tuesday morning, following Trump's tweet that he will make sure drug prices come "way down."
See which stocks are making big moves after the bell.
Investors are hopeful that Trump will wrap some details around tax reform and other programs when he speaks to Congress in the week ahead.
Sheryl Skolnick, Mizuho Securities, discusses her concerns surrounding the repeal of the Affordable Care Act, and what it means for hospital stocks.
As the Dow inches toward the 20,000-point milestone, analysts give predictions on sectors poised for growth in 2017.
Goldman Sachs options research team offers investors a strategy heading into the new year.
Hospitals that benefited under Obamacare likely will see a reversal of fortune and there are new risks for already struggling insurers.
Crossing President-elect Trump's path is proving to be treacherous and he's not even in office yet.